Cheryl Zimberlin, PhD, joined as an Analyst in May 2016. Cheryl received her BSc. Hons. in Biology from the University of Utrecht and her MSc in Biotechnology from the University of Wageningen, with a specializations in medical biology and cellular processing/ design, respectively. During her studies Cheryl additionally completed several University courses and internships in Sydney, AUS (University of Macquarie), Pretoria, RSA (University of Pretoria) and England, UK (University of York). In July 2016 she successfully defended her PhD, assessing the different progression stages of Colon Cancer, with a focus on epigenetics and apoptosis. Cheryl is based in Amsterdam.